SHAWN CARDOZA: Open Payments
NPI 1104937002 · VISALIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,438 in 174 payments from 25 companies in 2025. Trend: 2023 $2,211 · 2024 $2,301 · 2025 $2,438
Food & beverage: $2,438
| Company | Payments | Amount |
|---|---|---|
| TOLMAR, INC. | 32 | $240 |
| Amgen Inc. | 12 | $235 |
| Antares Pharma, Inc. | 14 | $229 |
| AstraZeneca Pharmaceuticals LP | 7 | $219 |
| ABBVIE INC. | 24 | $195 |
| Novo Nordisk Inc | 16 | $194 |
| Axsome Therapeutics, Inc. | 12 | $175 |
| PFIZER INC. | 17 | $173 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $149 |
| TG Therapeutics, Inc. | 1 | $127 |
Products named: JATENZO, XYOSTED, JARDIANCE, Auvelity, NURTEC ODT, VRAYLAR, BRIUMVI, Repatha.
Industry payments across CA — which companies pay providers there.
